NYSE:HAEMedical Equipment
Haemonetics Expands Hospital Portfolio As Investors Weigh Growth And Valuation
Haemonetics (NYSE:HAE) is expanding its product portfolio in the Hospital division with new technology and acquisitions.
The company has fully transitioned from legacy PCS2 plasma collection devices to its NexSys PCS system with Persona Technology.
Recent purchases of Attune Medica and OpSens add new capabilities in hospital and interventional cardiology settings.
For you as an investor, this shift is about more than one product line. Haemonetics operates across blood management and...